“上海产”康希诺新冠疫苗量产上市 - 2022年01月28日

Shanghai's first mass produced COVID-19 vaccine hit the market on Thursday from a newly launched vaccine gigafactory in the northern suburbs.

The single-dose vaccine from CanSino Biologics – called Convidecia – is the only one-shot COVID-19 vaccine among the seven novel coronavirus vaccines authorized for use in China. It can create antibody immunity in two weeks.

The first batch of the locally produced vaccines rolled off the automated production line at the gigafactory, covering more than 30,000 square meters in suburban Baoshan District.